SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-035278
Filing Date
2020-08-03
Accepted
2020-08-03 06:21:16
Documents
14
Period of Report
2020-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qtnt-8k_20200803.htm   iXBRL 8-K 30037
2 EX-99.1 qtnt-ex991_15.htm EX-99.1 460520
3 GRAPHIC gh54uawuic0n000001.jpg GRAPHIC 79102
  Complete submission text file 0001564590-20-035278.txt   750708

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20200803.xsd EX-101.SCH 5784
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20200803_lab.xml EX-101.LAB 19410
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20200803_pre.xml EX-101.PRE 11612
7 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-8k_20200803_htm.xml XML 3543
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 201067746
SIC: 2835 In Vitro & In Vivo Diagnostic Substances